Skip to main content
. 2017 Jun 1;19(11):1522–1531. doi: 10.1093/neuonc/nox105

Table 4.

Summary of adverse events

Adverse Event by CTCAE 4.0 All Grades n (%) Grade ≥ 3 n (%)
Patients with adverse events 47 (95.9) 20 (40.8)
Adverse events
 Rash 40 (81.6) 11 (22.4)
 Diarrhea 33 (67.3) 3 (6.1)
 Asthenia 11 (22.4) 2 (4.1)
 Nausea/vomiting 4 (8.2) 0 (0.0)